Hackensack Meridian Health EMERGE Program 2026 Finalist 10 of 60 solutions selected

CDVCA 2025 Unlock Capital National Cohort

One of thirty businesses selected to participate in the Community Development Venture Capital Alliance (CDVCA) 2025 national cohort. CDVCA is working to build and strengthen businesses in under-invested markets like maternal health. Participation in the cohort resulted in advocacy, education, communications and best practice dissemination to strengthen Vasowatch's commercialization strategy and investment positioning.

HiveBio inaugural cohort 2025

Vasowatch was selected as one of ten companies to participate in this inaugural hybrid accelerator designed to provide support to underrepresented life science entrepreneurs.

Selected to Participate in IGNITE Healthcare Accelerator 2024

Selected to participate in a powerful community of supporting women founders with the capital, resources, and know-how required to support startup growth.

NSF Regional I-Corp Program

In April 2024, Vasowatch completed the NSF Regional I-Corps Program, executing customer discovery interviews with twenty-one clinicians, healthcare administrators and technologists, key opinion leaders and payers, and further honing Vasowatch’s value proposition and go-to-market strategy.

MATTER Health 51 Labs Maternal Mortality Accelerator Participants

CEO Christine Rohan presented the Vasowatch solution at the conclusion of the 51 Labs cohort. 51 Labs is a women's health accelerator focused on one simple question: how can we prevent maternal mortality in the U.S. before, during and after birth?

2023 University Science Center Capital Readiness Program Participant

Vasowatch was selected to participate in the December 2023 University Science Center Capital Readiness Program, a 5-day intensive program preparing medtech, digital health, and healthcare technology startups to successfully raise funds with institutional investors.

2023 Ascend MedTech Accelerator

VentureWell has selected Vasowatch for their 2023 Ascend MedTech Accelerator as one of 20 med tech startups from across the nation that are launching high-impact medical devices, diagnostics, or software.

2023 mHUB Med Tech Accelerator Cohort

Vasowatch was one of ten high-potential medical device businesses identified by mHUB, one of the nation’s leading independent hardtech and manufacturing innovation centers, to join their 2023 6- month Med Tech Accelerator.

NIH course “Practical Implementation Science Principles for Product Development” NIH pilot course administered by RTI 4/26